Since the multiple subtypes of breast cancer are characterized by the expression of hormone receptors including estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), the nutritional programs which modulate both nutrition and hormone balance have gained interest as potential adjuvant therapy specifically for breast cancer [6]. This evidence concerns the gene NR4A1 and breast carcinoma.